Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Goodwill (2016 - 2025)

Veracyte (VCYT) has disclosed Goodwill for 12 consecutive years, with $767.2 million as the latest value for Q4 2025.

  • Quarterly Goodwill rose 2.86% to $767.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $767.2 million through Dec 2025, up 2.86% year-over-year, with the annual reading at $767.2 million for FY2025, 2.86% up from the prior year.
  • Goodwill hit $767.2 million in Q4 2025 for Veracyte, roughly flat from $767.2 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $773.3 million in Q2 2025 to a low of $471.8 million in Q2 2021.
  • Historically, Goodwill has averaged $700.3 million across 5 years, with a median of $706.2 million in 2021.
  • Biggest five-year swings in Goodwill: soared 26111.85% in 2021 and later fell 5.23% in 2022.
  • Year by year, Goodwill stood at $707.9 million in 2021, then dropped by 1.7% to $695.9 million in 2022, then rose by 1.02% to $703.0 million in 2023, then increased by 6.09% to $745.8 million in 2024, then grew by 2.86% to $767.2 million in 2025.
  • Business Quant data shows Goodwill for VCYT at $767.2 million in Q4 2025, $767.2 million in Q3 2025, and $773.3 million in Q2 2025.